MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial

NCT07505303 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Obesity
Weight Management

Interventions

DRUG: ECC4703
DRUG: Placebo
DRUG: Semaglutide

Sponsor

Eccogene